“USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS”. Mediterranean Journal of Hematology and Infectious Diseases 2, no. 1 (March 26, 2010): e2010003. Accessed April 30, 2026. https://www.mjhid.org/mjhid/article/view/2010.003.